Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
Background: Clarithromycin hypersensitivity is reported as the most common cause of non-β-lactam antibiotic allergy in children. Clarithromycin is frequently prescribed in cases of suspected β-lactam hypersensitivity. Oral provocation tests stand as the gold standard to confirm drug hypersensitivity as diagnostic value of skin tests is variable. We analyzed the frequency of true clarithromycin hypersensitivity ratio and its relationship with β-lactam allergy among children with suspected clarithromycin hypersensitivity and evaluated the diagnostic value of skin tests.
Methods: The study included 160 children referred with suspected clarithromycin hypersensitivity. Clinical history and allergy workups including skin tests or/and oral provocation tests were retrieved from medical records.
Results: Oral provocation test confirmed clarithromycin hypersensitivity rate was 5.6% (n = 9/160). Skin tests with clarithromycin showed positivity in 32.6% (n = 29/89) of the tested patients. The sensitivity of clarithromycin skin tests was negligible, and specificity was 73.9% (95% confidence interval [CI], 64.7-81.8). Eighty-eight of the patients (55%) reported that they had previously tolerated a β-lactam antibiotic. β-lactam hypersensitivity was suspected in 40% (n = 64/160) of the patients (simultaneous [n = 10], sequential [n = 19], distant form [n = 35]) in relation with clarithromycin usage. β-lactam hypersensitivity (95% CI, 2.1-70.6, p = .005) and sequential usage of clarithromycin after the development of a rash with amoxicillin-clavulanic acid (95% CI, 2.0-96.4, p = .007) were found as risk factors for confirmed clarithromycin hypersensitivity.
Conclusion: The frequency of confirmed clarithromycin hypersensitivity was found low among suspected patients. Oral provocation test is crucial for definite diagnosis. Confirmed β-lactam allergy may be attributed as a risk factor for clarithromycin hypersensitivity, particularly clarithromycin treatment after a developing rash with amoxicillin-clavulanic acid in sequential usage.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/pai.13588 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clarithromycin attenuates severe steroid hyporesponsive asthma by regulating type 2/type 17 inflammation balance and inhibiting mast cell activation.
Toxicol Appl Pharmacol
October 2025
School of Pharmacy, Xi'an Jiaotong University, Xi'an, China. Electronic address:
Asthma is a global notifiable disease that is mainly treated with glucocorticoids and airway relaxants. Some patients with neutrophilic airway inflammation are not sensitive to glucocorticoids therapy and there is no effective treatment available. Clarithromycin (CLA) is a commonly used macrolide antibiotic in clinical practice and is used in the treatment of lower respiratory tract infections.
View Article and Find Full Text PDFImmediate Hypersensitivity Reaction to Pheniramine in a Case of Multiple Drug Hypersensitivity Syndrome.
Cureus
February 2025
Allergy and Immunology, Adana City Training and Research Hospital, Adana, TUR.
Multiple drug hypersensitivity syndrome (MDHS) is a rare condition characterized by hypersensitivity reactions to at least two chemically unrelated drugs. While non-steroidal anti-inflammatory drugs and antibiotics are the most commonly implicated agents, hypersensitivity to antihistamines is extremely rare. A comprehensive approach, including detailed patient history, skin testing, and drug provocation tests, is essential for the accurate diagnosis and management of MDHS, particularly in patients with multiple drug reactions.
View Article and Find Full Text PDFIncidence of fidaxomicin allergy in patients with macrolide allergies: a large database analysis.
Antimicrob Agents Chemother
April 2025
Department of Medicine, Division of Infectious Diseases, University of Colorado, Aurora, Colorado, USA.
Fidaxomicin may exhibit cross-reactivity in patients with known macrolide allergies. In this analysis, compared to patients without macrolide allergies, the odds of fidaxomicin allergy were 2.31, 8.
View Article and Find Full Text PDFAntibiotic-induced IgA vasculitis: insights from a real-world retrospective analysis and pharmacovigilance assessment.
Arch Dermatol Res
February 2025
Department of Pediatrics, The Third Xiangya Hospital, Central South University, No. 138 Tongzipo Road, Changsha, 410013, Hunan, China.
IgA vasculitis (IgAV) is a small-vessel vasculitis characterized by the deposition of immunoglobulin A (IgA) in the vessel walls, often presenting with cutaneous manifestations such as palpable purpura. Drug-induced IgAV is a rare but potentially severe condition. Several studies have suggested a possible association between antibiotics and IgAV.
View Article and Find Full Text PDFAge-stratified analysis of adverse event signals for clarithromycin: a disproportionality analysis using the FDA Adverse Event Reporting System.
Ther Adv Drug Saf
January 2025
College of Pharmacy, Jinan University, Guangzhou, Guangdong 511436, China.
Article Synopsis
- The study examines the adverse events (AEs) linked to clarithromycin, an antibiotic, across different age groups using data from the FDA Adverse Event Reporting System (FAERS).
- Common AEs include vomiting and diarrhea in younger age groups, while older adults experience issues like abnormal taste and drug interactions.
- Eighteen age-specific signals were identified, highlighting the need for tailored monitoring and management of clarithromycin's safety profile in different age demographics.